¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other antenatal screening for based on amniocentesis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® screening ÇÑ±Û °Ë»ö, ¼±º°
¼³¸í   
  1. º¸±â¿¡´Â °Ç°­ÇÑ °Í°ú °°ÀÌ º¸À̸鼭 Áúº´¿¡ °É·ÁÀÖ´Ù°í »ý°¢µÇ´Â »ç¶÷µéÀ» °ñ¶ó³»±â À§ÇÑ °Ë»ç. Áúº´ÀÇ Áø´ÜÀ» ÀǵµÇÑ °ÍÀº ¾Æ´Ï°í ´Ù¼öÀÇ ¼öÀüÀÚ Áß¿¡¼­ ºñ±³Àû °£´ÜÇÑ ¹æ¹ýÀ¸·Î ÀǽÉÀÌ °¡´Â ÀÚ¸¦ °ñ¶ó³»´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ¼±ÃâµÈ Àڴ ´õ¿í »ó¼¼ÇÑ °Ë»ç¸¦ ¹ÞÀ» Çʿ䰡 ÀÖ´Ù. 2. ½ÃÇèÀ̳ª °Ë»ç¿Í °°Àº ¿¹ºñÀû ÀýÂ÷, Á¶»ç°¡ ´õ ÇÊ¿äÇÑ Àå¾ÖÀÇ °¡Àå Æ¯Â¡ÀûÀΠ¡Èĸ¦ Ã£¾Æ³»±â À§ÇØ ½ÃÇàÇÑ´Ù. 3. Áý´Ü¼±º°°Ë»ç, °íÇ÷¾Ð°ú °°Àº Æ¯Á¤º´À̳ª Àå¾Ö¸¦ Ã£¾Æ³»±â À§ÇØ Å« Ç¥º»À» ÀÌ¿ëÇϴ °Ë»ç.
¿µ¹® amniocentesis ÇÑ±Û ¾ç¼öõÀÚ
¼³¸í   
  ÀӽŽàÀڱó»¿¡¼­ Å¾ƴ ¾ãÀº ¸·¿¡ µÑ·¯½×¿© ÀÖ°í ÀÌ ¸·°ú Å¾Ơ»çÀÌ¿¡´Â ¾×ü°¡ ÀÖ´Ù. ÀÌ ¸·À» ¾ç¸·À̶ó°í ÇÏ°í ¾ç¸·¼ÓÀÇ ¾×ü¸¦ ¾ç¼ö(amniotic fluid)¶ó°í ÇÑ´Ù. Å¾ƱâÀÇ ÀÌ»óÀ» Áø´ÜÇϱâÀ§Çؼ­ ÀÌ ¾ç¼ö¸¦ »Ì¾Æ¼­ °Ë»ç¸¦ ÇÒ ¼ö Àִµ¥ ÀÌ·¸°Ô ¾ç¼ö¸¦ »ê¸ðÀÇ ¹è¿¡¼­ ÁÖ»ç±â·Î »Ì´Â ÇàÀ§¸¦ ¾ç¼öõÀÚ¶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amniocentesis
    ¾ç¸·ÃµÀÚ, ¾ç¼öõÀÚ
  • evidence-based medicine
    Áõ°ÅÁß½ÉÀÇÇÐ, Áõ°Å¹ÙÅÁÀÇÇÐ
  • evidence-based practice
    Áõ°ÅÁß½ÉÁø·á, Áõ°Å¹ÙÅÁÁø·á
  • egg-based medium
    ´Þ°¿±âÃʹèÁö
  • fornix-based conjunctival flap
    ¿ø°³°á¸·ÆÇ
  • limbus-based conjunctival flap
    À±ºÎ°á¸·ÆÇ
  • problem based learning
    ¹®Á¦¹ÙÅÁÇнÀ
  • resource based relative value scale
    ÀÚ¿ø±âÁØ»ó´ë°¡Ä¡µî±Þ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • Denver Developmental Screening Test
    µ§¹ö¹ß´Þ¼±º°°Ë»ç
  • genetic screening
    À¯Àü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • multiphasic screening
    ´Ù»ó¼±º°°Ë»ç
  • mass screening
    Áý´Ü¼±º°°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amniocentesis
    ¾ç¸·ÃµÀÚ, ¾ç¼öõÀÚ
  • problem based learning
    ¹®Á¦¹ÙÅÁÇнÀ
  • screening
    °Ë»ö, ¼±º°, °Ë»ç
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amniocentesis
    ¾ç¸·ÃµÀÚ, ¾ç¼öõÀÚ
  • fornix-based conjunctival flap
    ¿ø°³°á¸·ÆÇ
  • limbus-based conjunctival flap
    À±ºÎ°á¸·ÆÇ
  • resource based relative value scale
    Áö¿ø±âÁØ»ó´ë°¡Ä¡
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • mass screening
    Áý´Ü°Ë»ç
  • multiphasic screening
    ´Ù´Ü°è¼±º°, ´Ù»ó°ËÁø
  • multiphasic screening test
    ´Ù»ó¼±º°°Ë»ç
  • prescriptive screening
    ó¹æÀû¼±º°¹æ¹ý
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • screening coordinate recorder
    ÁÖ»ç½ÄÁÂÇ¥±â·Ï±â
  • screening
    °Ë»ö, ¼±º°
  • screening test
    ¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • amniocentesis
    ¾ç¼öõÀÚ(åÏâ©ô¾ô§).
  • amniocentesis
    ¾ç¸·ÃµÀÚ(åÏØ¯ô¾í©)
  • amniocentesis
    ¾ç¼öõÀÚ
  • DDST=Denver developmental screening test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atypical, mixed or other personality
    ºñÁ¤Çü ³»Áö È¥ÀçÇü ¶Ç´Â ±âŸ ÀΰÝ
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • amniocentesis
    ¾ç¼öõÀÚ(åÏâ©ô¾ô§).
  • amniocentesis
    ¾ç¸·ÃµÀÚ(åÏØ¯ô¾í©)
  • amniocentesis
    ¾ç¼öõÀÚ
  • amniocentesis
    ¾ç¼ö õÀÚ (åÏâ© ô¾í©)
  • fornix-based conjunctival flap
    ¿ø°³(±âÀú)°á¸·Æí
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • limbus-based conjunctival flap
    À±ºÎ(±âÀú)°á¸·Æí
  • resource based relative value scale(RBRVS)
    Áö¿ø±âÁØ »ó´ë°¡Ä¡, ÀÇ·á¼ö°¡ Ã¥Á¤ÀÇ Åä´ë·Î Ȱ¿ëµÊ.
  • resource-based relative value system
    ÀÚ¿ø¿¡ ±Ù°ÅÇÑ »ó´ëÀû °¡Ä¡Ã¼°è
  • tumor immunity,antibody-based therapy
    Ç×ü¿¡ ÀǰÅÇÑ Ä¡·á
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mass screening
    Áý´Ü°Ë»ç
  • screening test
    ¼±º°°Ë»ç
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antenatal
    Ȑ˟˂
  • gadolinium based contrast agent
    °¡µ¹¸®´½Á¶¿µÁ¦
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • screening
    ½ºÅ©¸®ÀÌ´×, ¼±º°¹ý
  • screening test
    ¼±º°°Ë»ç, ¿¹ºñ°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
DAST drug abuse screening test; drug and alcohol screening test
AN acanthosis nigricans; acne neonatorum; acoustic neuroma; adult, normal; ala nasi; amyl nitrate; aneu...
A/N antenatal; as needed
ANC Antenatal care
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EA Early amniocentesis
ANC Antenatal Care
ANC Antenatal clinics
DRO Differential Reinforcement of Other Behaviour
MOTT Mycobacteria Other Than Tuberculosis
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Z36.2
    Other antenatal screening for based on amniocentesis
    ±âŸ ¾ç¸·ÃµÀÚ¿¡ ±âÃÊÇÑ Ãâ»êÀü ¼±º°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amniocentesis
    ¾ç¼ö õÀÚ
    žÆÀÇ ÀÌ»óÀ» Áø´ÜÇϱâ À§ÇØ ¾ç¼ö¸¦ »ê¸ðÀÇ ¹è¿¡¼­ ÁÖ»ç±â·Î »Ì´Â °Í.
  • broad based tumor
    ±âÀúºÎ°¡ ³ÐÀº Á¾¾ç
  • broad-based cherry-size
    ±âÀúºÎ°¡ ³ÐÀº ü¸® Å©±âÀÇ
  • Denver developmental screening test
    µ§¹ö ¹ßÀ° ¼±º° °Ë»ç, µ§¹ö ¹ßÀ° ¼±º°¹ý
    ¹ßÀ° ºÎÁøÀÌ ÀÖ´Â ¿µ¾Æ³ª ÇÐ·É Àü±â ¾Æµ¿À» ½Äº°ÇÏ´Â °Ë»ç¹ý.
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • other abnormality
    ±âŸ ÀÌ»ó
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • other mycoses
    ±âŸ Áø±ÕÁõ
  • screening device
    °Ë»ö ±â±â
  • screening examination
    °£ÀÌ °Ë»ç
  • screening history
    °£ÀÌ º´·Â Á¶»ç
  • screening test
    ¼±º° °Ë»ç, ¿¹ºñ °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
amniocentesis <procedure, obstetrics> Sampling of the fluid in the amniotic sac. In humans this is carried out, between the 12th and 16th week of pregnancy, by inserting a needle through the abdominal wall into the uterus.
By karyotyping the cells and determining the proteins present, it is possible to determine the sex of the foetus and whether it is suffering from certain congenital diseases such as Down's syndrome or spina bifida.
(05 Feb 1998)
antenatal <epidemiology> The period between conception and birth. Same as prenatal.
(05 Dec 1998)
antenatal diagnosis Determination of the nature of a pathological condition or disease in the postimplantation embryo, foetus, or pregnant female before birth.
(12 Dec 1998)
other-directed Pertaining to a person readily influenced by the attitudes of others.
(05 Mar 2000)
transferases (other substituted phosphate groups) <enzyme> A class of enzymes that transfers substituted phosphate groups.
Registry number: EC 2.7.8
(12 Dec 1998)
mechanism-based inhibitor A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme.
Synonym: mechanism-based inhibitor.
(05 Mar 2000)
competency-based education Educational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives.
(12 Dec 1998)
problem-based learning Instructional use of examples or cases to teach using problem-solving skills and critical thinking.
(12 Dec 1998)
home care services, hospital-based Hospital-sponsored provision of health services, such as nursing, therapy, and health-related homemaker or social services, in the patient's home. (hospital administration terminology, 2d ed)
(12 Dec 1998)
evidence-based medicine The process of systematically finding, appraising, and using contemporaneous research findings as the basis for clinical decisions. Evidence-based medicine asks questions, finds and appraises the relevant data, and harnesses that information for everyday clinical practice. Evidence-based medicine follows four steps: formulate a clear clinical question from a patient's problem; search the literature for relevant clinical articles; evaluate (critically appraise) the evidence for its validity and usefulness; implement useful findings in clinical practice. The term "evidence based medicine" (no hyphen) was coined at mcmaster medical school in canada in the 1980's to label this clinical learning strategy, which people at the school had been developing for over a decade.
(12 Dec 1998)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
genetic screening The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia.
(09 Oct 1997)
carrier screening Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk.
(05 Mar 2000)
mass screening Organised periodic procedures performed on large groups of people for the purpose of detecting disease.
(12 Dec 1998)
vision screening Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amniocentesis
    ¾ç¸·ÃµÀÚ
  • screening
    üÁúÇϱâ;½É»ç;°¡¸®±â;Â÷Æä
  • antenatal
    Ãâ»ýÀüÀÇ
  • antenatal
    Ãâ»ýÀüÀÇ
  • zero-based
    Á¦·Îº£À̽ºÀÇ
  • based
    ±Ù°Å°¡ ÀÖ´Â...;¿¡ ±âÁö(±â¹Ý)¸¦ µÐ
  • character-based
    ¹®ÀÚ ´ÜÀ§ Ç¥½Ã ¹æ½ÄÀÇ
  • computer-based learning
    ÄÄÇ»Å͸¦ ÇнÀÀÇ µµ±¸·Î ÀÌ¿ëÇϱâ
  • each other
    ¼­·Î
  • in some way or other
    ¾î¶»°Ô ÇØ¼­µçÁö
  • other
    ±×¹ÛÀÇ
  • some other time
    ¾ðÁ¨°¡ µý³¯¿¡(=some other day)
  • t'other
    ¶Ç Çϳª
  • A.N. Other
    ÀÍ¸í¾¾;¼±¼ö ¹ÌÁ¤
  • other
    µý;´Ù¸¥;´ÙÀ½ÀÇ;³ª¸ÓÁöÀÇ;every ~ Çϳª°É·¯;none ~ than ´Ù¸§ ¾Æ´Ñ;the ~ day(night)ÀÏÀü(¿äÀü³¯ ¹ã)¿¡;the ~ party »ó´ë¹æ;the ~ side (¹Ì±¹¿¡¼­ º») À¯·´;the ~ world ³»¼¼;Àú½Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á